JW LIFESCIENCE CORPORATION
Founded in 1994, JW Life Science is an IV fluid specialist producing basic fluids, TPN, and specialty fluids, with a license-out agreement with Baxter.
As of 2026-10-11, JW LIFESCIENCE CORPORATION has 46 Korean MFDS drug approvals on record (counted by the MAA Company Index from its own matching of public databases).
Price
Change
Market cap
Business overview
Source: DART corporate disclosureFounded in 1994 and listed on KOSPI in 2016, JW Life Science is a pharmaceutical company specializing in intravenous fluids. Its product lineup includes basic IV fluids, total parenteral nutrition (TPN), specialty fluids, and HEMO products; it has developed proprietary Non-PVC materials and signed an exclusive license-out and export agreement with Baxter of the US. In its 32nd fiscal year, separate-entity revenue was about KRW 234 billion, with affiliate JW Pharmaceutical accounting for over 75.9% of sales, and its TPN production facility has obtained EU-GMP certification.
Products & technology
- Basic IV FluidsBasic intravenous fluid products
- TPN (Total Parenteral Nutrition)High value-added total parenteral nutrition product using proprietary Non-PVC materials
- Specialty IV FluidsSpecialty intravenous fluid products
- HEMOIV fluid product line
Regulatory approvals
data.go.kr46 Korean MFDS drug approvals · 1977–2026
- MFDS drugPlajudex injection2026-05-29Drug · Prescription · Approval202601573
- MFDS drugPowerargine Inj. (L-arginine hydrochloride)2024-12-16Drug · Prescription · Approval202402962
- MFDS drugWINUF A PLUS Peri inj.2023-08-31Drug · Prescription · Approval202302603
- MFDS drugWINUF A PLUS Inj.2023-06-28Drug · Prescription · Approval202301977
- MFDS drugPreburofen Injection (Ibuprofen)2022-04-28Drug · Prescription · Approval202201730
- MFDS drugFluenpera Inj.2021-07-28Drug · Prescription · Approval202105581
- MFDS drugJsedex Inj.2020-11-12Drug · Prescription · Approval202007831
- MFDS drugLipision A Inj.2020-10-21Drug · Prescription · Approval202007209
- MFDS drugFinamoa Tab. 1mg2019-08-23Drug · Prescription · Approval201905988
- MFDS drugDutamoa Tab. 0.5mg2019-08-22Drug · Prescription · Approval201905934
- MFDS drugAcetaphen Inj.2019-05-10Drug · Prescription · Approval201903045
- MFDS drugCleancle (Irrigation Sol.)2017-06-09Drug · OTC · Notification201703175
Show 34 more
- MFDS drugLevetiram Inj. 1000mg2017-01-10Drug · Prescription · Approval201700234
- MFDS drugLevetiram Inj. 500mg2016-08-31Drug · Prescription · Approval201605338
- MFDS drugMomederm Cream2014-11-21Drug · Prescription · Notification201405441
- MFDS drugPregaton Tab.2014-10-14Drug · Prescription · Approval201404705
- MFDS drugJW Linezolid Inj.Revoked2014-09-15Drug · Prescription · Approval201404222
- MFDS drugJW 5% Dextrose Inj.2014-02-26Drug · Prescription · Notification201400872
- MFDS drugJW Moxifloxacin Inj. 400mg2013-10-22Drug · Prescription · Approval201309860
- MFDS drugWinuf Inj.2013-09-30Drug · Prescription · Approval201309522
- MFDS drugWinuf Peri Inj.2013-09-30Drug · Prescription · Approval201309523
- MFDS drugMoxamentin Duo Syr.2012-10-22Drug · Prescription · Notification201207318
- MFDS drugJW Levofloxacin Inj.2012-04-19Drug · Prescription · Notification201203044
- MFDS drugNa.K Inj. 2002012-02-23Drug · Prescription · Notification201201138
- MFDS drugCombiflex MCT Peri Inj.2008-10-16Drug · Prescription · Notification200810459
- MFDS drugLavosol Inj.2008-05-27Drug · Prescription · Notification200805884
- MFDS drugEveramin Inj.2008-05-21Drug · Prescription · Notification200805674
- MFDS drugDoctoramin Inj.2008-05-19Drug · Prescription · Notification200805596
- MFDS drugCombiflex Lipid Central Inj.2008-03-14Drug · Prescription · Notification200802850
- MFDS drug10% Dextrose & Sodium.Potassium Inj. 12007-09-18Drug · Prescription · Notification200710602
- MFDS drug10% Dextrose & Sodium.Potassium Inj. 22007-09-18Drug · Prescription · Notification200710603
- MFDS drug0.9% NaCl.K 40 Inj.2007-09-18Drug · Prescription · Notification200710605
- MFDS drugPlaju OP Inj.2006-11-08Drug · Prescription · Notification200606562
- MFDS drugCombiflex Lipid Peri Inj.2006-04-05Drug · Prescription · Notification200601057
- MFDS drugCombiflex Lipid Inj.Revoked2006-04-05Drug · Prescription · Notification200601056
- MFDS drugLipision 10% Inj.2006-04-05Drug · Prescription · Notification200601052
- MFDS drugLipision 20% Inj.2006-04-05Drug · Prescription · Notification200601053
- MFDS drugChoong Wae Normal Saline Inj.2006-02-23Drug · Prescription · Notification200601050
- MFDS drugChoong Wae Hemo B-2 Sol.2006-02-23Drug · Prescription · Approval200601051
- MFDS drugDoctoramin Gold Inj.2004-12-30Drug · Prescription · Notification200400214
- MFDS drugJW Life Ciprofloxacin Injection2002-03-02Drug · Prescription · Notification200200238
- MFDS drugYouvasol Injection1997-09-26Drug · Prescription · Notification199700387
- MFDS drugJ-Hepamin Inj.1997-02-05Drug · Prescription · Notification199700383
- MFDS drugNewtamin Inj.1996-08-29Drug · Prescription · Notification199600268
- MFDS drugBoin ACDA Soln.1996-05-09Drug · Prescription · Notification199603382
- MFDS drugEvasol Injection1977-02-26Drug · Prescription · Notification197700052
Clinical trials
data.go.kr2 MFDS clinical trial authorisations · 2021 (Phase 3 2)
- Phase 3위너프에이플러스페리주2021-05-27
6 trial sites
- Phase 3위너프에이플러스주2021-05-27
7 trial sites
R&D and key agreements
Source: DART corporate disclosureHP연구센터 수액기술 연구개발 · Proprietary Non-PVC material development and R&D in high-quality pharmaceuticals and plant engineering
Patents
KIPRIS · applicant-matchedRegistered · 2023-12 · Application 1020230172322
Registered · 2023-05 · Application 1020230060770
Registered · 2020-09 · Application 1020200124532
Registered · 2020-04 · Application 1020200041705
Registered · 2019-11 · Application 1020190138831
Expired · 2016-06 · Application 2020160003012
Registered · 2016-05 · Application 2020160002770
Registered · 2016-03 · Application 1020160033024
Expired · 2015-07 · Application 2020150005163
Registered · 2011-11 · Application 1020110115871
Show 16 more patents
Expired · 2011-09 · Application 1020110097972
Registered · 2009-06 · Application 1020090050454
Registered · 2009-04 · Application 1020090029429
Registered · 2009-04 · Application 1020090029396
Registered · 2008-12 · Application 1020080129909
Registered · 2008-12 · Application 1020080129910
Registered · 2008-11 · Application 1020080119451
Expired · 2008-11 · Application 1020080116663
Registered · 2008-09 · Application 1020080093041
Expired · 2008-06 · Application 1020080055075
Registered · 2008-04 · Application 1020097020879
Expired · 2007-10 · Application 1020070110181
Expired · 2005-11 · Application 1020050110933
Expired · 2004-06 · Application 1020040043404
Rejected · 2003-06 · Application 1020030043921
Expired · 2002-07 · Application 1020020039411
AI reads
MAA server logs · IP-verifiedPulled records become part of each AI's index and keep feeding its answers. When an AI cites from that index, nothing reaches our server — so actual citations are uncounted here and exceed this number.
Times an AI needed something not yet in its index and fetched this page fresh while answering. Citations served from the index leave no trace here.
Collected as raw material for future answers.
Queries from users who connected this index to their own AI.
- OpenAIOAI-SearchBot69
- PerplexityPerplexityBot2
- AnthropicClaudeBot2
- MicrosoftBingbot1
- GoogleGoogleOther1
Measured since Aug 26, 2026 · 5 AI engines · last read Oct 10, 2026
User-agent strings can be forged, so we do not count them at face value. We count only requests matched against vendor-published IP ranges, or confirmed by forward-verified reverse DNS. MCP queries are actual calls to this index's tool endpoint.
Connect this company index directly to your AI
Connect it to ChatGPT or Claude, and your AI queries the full record — profiles, financials, stock data, regulatory approvals, clinical trials, publications and patents — for JW LIFESCIENCE CORPORATION and every listed Korean medical, bio and AI company.
How to connect (MCP)Companies in the same categoryPharma & CDMO
Founded in 1941 and listed on the KOSPI in 1975, Ildong Holdings is the holding company of the Ildong Pharmaceutical Group, overseeing pharmaceutical, aesthetic medical device, and drug development affiliates.
Founded in 1941 and listed on the KOSPI in 1975, Yuyu Pharma is a pharmaceutical company with a co-promotion agreement with Dong-A ST for Tanamin.
Founded and listed on the KOSPI in 2016, Il Dong Pharmaceutical manufactures products including the Aronamin vitamin line.
Founded 2000, KOSDAQ-listed 2009, Medy-Tox develops and exports botulinum toxin biopharmaceuticals including Meditoxin and Innotox.
KOSPI-listed comprehensive pharmaceutical company specializing in blood products and vaccines, with FDA-approved immunoglobulin ALYGLO.
KOSPI-listed pharmaceutical company behind Coldwon cold medicine and Jangdaewon probiotics, developing a P-CAB drug pipeline.
Founded 2011, listed 2016 — Samsung Biologics is a biopharma CDMO with 785,000L capacity across five Songdo plants.
Founded in 2006 and listed on KOSDAQ in 2020, Genolution is a molecular diagnostics and RNAi company producing nucleic acid extraction reagents and devices.
Ahn-Gook Pharmaceutical sells the cough/expectorant drug Sinecuran and the eye-health supplement Tobicom.
Founded in 2003 and listed on KOSDAQ in 2015, Corestem Chemon develops stem cell therapies and provides nonclinical CRO services, including the ALS treatment Neuronata-R.
Founded 2005, KOSDAQ-listed 2022, BIO-FD&C develops plant-cell platform-based cosmeceutical materials and biopharma pipelines.
KOSPI-listed comprehensive pharma company behind Amaryl diabetes drug and the USD 86.25M HL5101 anticancer out-license deal.
Sources and updates
Counts on this page are not company-reported figures. MAA matched records from DART, the Korean MFDS, the US FDA, ClinicalTrials.gov, PubMed and KIPRIS to this company itself, by business registration number or registered name, never by name similarity. They may differ from figures the company publishes.
- Company basics
- Korea Exchange · DART
- Business content
- Compiled from disclosure filings
- Approvals & clinical trials
- Korean MFDS (data.go.kr) · US FDA openFDA — updated weekly
- Key disclosures
- KRX KIND via OpenDART exchange filings — updated daily
- Global clinical trials
- ClinicalTrials.gov (US NIH) — sponsor-matched, updated weekly
- Financials
- DART corporate disclosure filings — annual
- Publications
- PubMed (US National Library of Medicine) — affiliation-matched, updated daily
- Patents
- KIPRIS (Korea Institute of Patent Information) — applicant-matched, updated monthly
- AI reads
- Our server logs, IP-verified every 6 hours
- AI visibility
- Measured 2026-10-01
This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.
Request a correction or addition